Feng Ren
Net worth: 3 M $ as of 30/05/2026
Net worth: 3 M $ as of 30/05/2026
Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/12/2025 | 475,400 ( 0.08% ) | 3 M $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Chief Executive Officer | 31/05/2022 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| SHANGHAI MEDICILON INC. | Corporate Officer/Principal | 31/12/2020 |
| GSK PLC | Director/Board Member | 31/12/2017 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Medicilon, Inc.
Shanghai Medicilon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and develop biotechnology drug discovery contract research organization | Commercial Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Technology Services |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
Select your edition
All financial news and data tailored to specific country editions